2017 April, 25 Interview with Oncology Venture Sweden AB in Berlingske Tidende Read more
(WorldNews Denmark)

2017-04-25 Hoersholm, Denmark, April 25th, 2017 - On April 24 the Danish newspaper Berlingske Tidende published an interview by business journalist Thomas Mikkel Mortensen med Oncology Venture Sweden AB`s CEO Peter Buhl Jensen. . About MPI`s multiple biomarker called Drug Response Predictor - DRP(TM) MPI`s DRP(TM) is a tool for developing tumor-derived genetic signatures to predict which cancer patients are high likely to respond to a given anti-cancer product. The DRP(TM) has been tested in 37...